$ANTX
AN2 Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ANTX up today? It is at $5.81 (+0.35%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ANTX spikes, and full due diligence on ANTX — key stats, earnings, dilution and insider activity. Free.
Get free $ANTX alerts the moment volume spikes
Our scanner flagged $ANTX 10 times in the last 30 days. Create a free account to track $ANTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $5.81
- Change today
- +0.35%
- Previous close
- $5.79
- 52-week range
- $1.00 – $7.19
- Market cap
- $219M
- Short interest
- 2.4M ▼ -2% vs prior · as of 2026-07-31
- Short % of float
- 6.4%
- Days to cover
- 14.8d
- Avg daily volume
- 477K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 1.4x
- 15m
- 1.6x
- 1h
- 2.4x
- 1D
- --
Get free ANTX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ANTX moving today?
Here is the latest on ANTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ANTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Analyst data via Nasdaq. Not investment advice.
Insiders
3 buys, 4 sells last 3 months (17/15 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Readnour Robin Shane Director | Sold (automatic/other) | -35K 0.09% of company | sold 2.9% | 1.20M | $213K at $6.01 | Aug 17, 26 |
Zakrzewski Joseph S Director | Sold (automatic/other) | -406K 1.1% of company | n/a | n/a | n/a | Aug 14, 26 |
Martin Patricia A. Director | Acquired (grant/award) | +766 | added 4.2% | 19K | n/a | Jul 10, 26 |
Marks Gilbert Lynn Director | Acquired (grant/award) | +3K | added 3.5% | 82K | n/a | Jul 10, 26 |
Aziz Kabeer Director | Acquired (grant/award) | +3K | added 5.1% | 59K | n/a | Jul 10, 26 |
Eizen Joshua M Officer | Sold (automatic/other) | -6K 0.02% of company | sold 2.8% | 207K | $25K at $4.17 | Jul 8, 26 |
Williams Sarah Joanne Officer | Sold (automatic/other) | -265 | sold 0.4% | 67K | $1K at $4.43 | May 29, 26 |
Martin Patricia A. Director | Acquired (grant/award) | +1K | added 7.1% | 18K | n/a | Apr 10, 26 |
Marks Gilbert Lynn Director | Acquired (grant/award) | +4K 0.01% of company | added 5.0% | 79K | n/a | Apr 10, 26 |
Aziz Kabeer Director | Acquired (grant/award) | +4K 0.01% of company | added 7.2% | 56K | n/a | Apr 10, 26 |
Williams Sarah Joanne Officer | Sold (automatic/other) | -327 | sold 0.5% | 67K | $347 at $1.06 | Mar 3, 26 |
Chanda Sanjay Officer | Acquired (grant/award) | +38K 0.1% of company | added 47% | 119K | n/a | Feb 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $ANTX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 14,035,104 new shares
- About $300.0M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ANTX Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ANTX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to ANTX
Comparable names in pharmaceutical preparations, closest in size first.
ANTX stock FAQ
Why is $ANTX moving today?
Here is the latest on ANTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ANTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the ANTX stock price today?
ANTX last traded at $5.81, up 0.35% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ANTX alerts?
The ANTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ANTX 10 times in the last 30 days.
What exchange is ANTX on?
ANTX (AN2 Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $219M in the PHARMACEUTICAL PREPARATIONS sector.
Is ANTX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ANTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.